Intrinsic Value of S&P & Nasdaq Contact Us

Madrigal Pharmaceuticals, Inc. MDGL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
54/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$705.67
+34.4%

Madrigal Pharmaceuticals, Inc. (MDGL) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, ACLX, DAWN, ETNB, HEPA, ICPT and others.

MDGL has a market capitalization of $12.04B, compared to an average peer market cap of $2.3B. MDGL is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message